Business Context and Reporting Period
Company: Exicure, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 30, 2021
Reporting Period: Event date of September 30, 2021
Exicure, Inc., an emerging growth company incorporated in Delaware, reported the entry into a material definitive agreement regarding its credit facilities.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, or margins. The document focuses exclusively on a specific debt agreement amendment.
- Debt Instrument: Credit and Security Agreement with MidCap Financial Trust (as agent) and other lenders.
- Facility Amount: Amendment No. 3 pertains to a second advance of $7.5 million.
- Liquidity Condition: Access to the $7.5 million advance is contingent upon the Company raising at least $20.0 million in unrestricted net cash proceeds from equity issuance.
Material Changes
The primary material change reported is the extension of the availability period for the second advance under the Credit Agreement.
- Previous Deadline: September 30, 2021.
- New Deadline: December 31, 2021.
- Conditions Precedent: The extension is subject to the Company satisfying funding conditions, specifically the issuance of equity interests resulting in the receipt of at least $20.0 million in unrestricted net cash proceeds and the contribution of such proceeds to Exicure Operating Company.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on operations, or a discussion of general risks. The document highlights a specific contingency regarding the Company's ability to access debt financing.
- Contingency: The ability to draw the $7.5 million advance is not guaranteed and depends entirely on the successful completion of an equity raise of at least $20.0 million by December 31, 2021.
- Unusual Items: None reported beyond the amendment to the credit agreement.
Investor Verification Checklist
- Verify whether Exicure, Inc. has successfully issued equity interests to raise the required $20.0 million in unrestricted net cash proceeds.
- Confirm if the $7.5 million second advance under the Credit Agreement has been drawn or if the deadline of December 31, 2021, has passed without satisfaction of conditions.
- Review the full text of Amendment No. 3 (Exhibit 10.1) for specific limitations on equity issuance and other funding conditions.
- Check subsequent filings for updates on the Company's liquidity status and capital structure.